Term ends Nov 15, 2026 · High confidence
20-year base term ends Nov 15, 2026
Held by Array Biopharma Inc.
Filed Sep 8, 2022 as application 17/940,902 · Granted Dec 24, 2024
Base term, 20 years from filing
Today
2006
2026
Clock starts
Nov 15, 2006
Nov 15, 2006
Term ends
Nov 15, 2026
Nov 15, 2026
Granted
Dec 24, 2024
Dec 24, 2024
base term
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
None due
Maintenance fees
This term ends before the first maintenance fee's grace period does, 4 years from grant, so no fee can end it early.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. No maintenance fee can end this term early. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 15, 2006, when application PCT/US2006/044431, the earliest non-provisional in its chain, was filed (this one was filed Sep 8, 2022) | Nov 15, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | No maintenance fee can end the term early | In force | High confidence |
| Computed term end | The steps above, in order | Nov 15, 2026 | High confidence |
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 25, 2022 Reel 61529, frame 93 | Lyssikatos, Joseph P.; Hicks, Julie Marie; Marmsater, Fredrik P.; Zhao, Qian | Array Biopharma Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Nov 2026
Term ends Nov 15, 2026. No further fees fall due before then
Citations
0
later US patents cite this one
Fewer than half of the utility patents granted in 2024 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.